Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
2.400
+0.010 (0.42%)
At close: Nov 20, 2026, 4:00 PM EST
2.390
-0.010 (-0.42%)
After-hours: Nov 20, 2026, 4:10 PM EST
Apyx Medical Market Cap
Apyx Medical has a market cap or net worth of $101.1 million as of November 20, 2026. It is the 24,487th most valuable company in the world and the 3,968th biggest in the United States. Its market cap has decreased by 33.09% in one year.
Market Cap
101.10M
Enterprise Value
115.07M
1-Year Change
-33.09%
Global Rank
Country Rank
#3,968 United States
Category
ChartMarket Cap Chart
Since February 22, 1999, Apyx Medical's market cap has increased from $10.20M to $101.10M, an increase of 891.15%. That is a compound annual growth rate of 8.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 101.10M | -24.44% |
| Dec 31, 2025 | 133.80M | 144.61% |
| Dec 31, 2024 | 54.70M | -39.76% |
| Dec 29, 2023 | 90.80M | 12.10% |
| Dec 30, 2022 | 81.00M | -81.60% |
| Dec 31, 2021 | 440.30M | 78.40% |
| Dec 31, 2020 | 246.80M | -14.63% |
| Dec 31, 2019 | 289.10M | 34.34% |
| Dec 31, 2018 | 215.20M | 151.99% |
| Dec 29, 2017 | 85.40M | -13.12% |
| Dec 30, 2016 | 98.30M | 72.15% |
| Dec 31, 2015 | 57.10M | -13.62% |
| Dec 31, 2014 | 66.10M | 72.58% |
| Dec 31, 2013 | 38.30M | -10.93% |
| Dec 31, 2012 | 43.00M | 14.36% |
| Dec 30, 2011 | 37.60M | -35.28% |
| Dec 31, 2010 | 58.10M | -56.48% |
| Dec 31, 2009 | 133.50M | 31.92% |
| Dec 31, 2008 | 101.20M | 2.64% |
| Dec 31, 2007 | 98.60M | -26.20% |
| Dec 29, 2006 | 133.60M | 221.93% |
| Dec 30, 2005 | 41.50M | 17.90% |
| Dec 31, 2004 | 35.20M | -12.87% |
| Dec 31, 2003 | 40.40M | 213.18% |
| Dec 31, 2002 | 12.90M | 21.70% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TriSalus Life Sciences | 143.14M |
| MaxCyte | 141.45M |
| Inogen | 137.81M |
| Pulmonx | 111.93M |
| Neuronetics | 97.16M |
| Quanterix | 93.06M |
| Perspective Therapeutics | 91.03M |
| Owlet | 87.58M |